Niagen Bioscience (NAGE) Assets Growth (5y) (2016 - 2025)
Niagen Bioscience (NAGE) Assets Growth (5y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Niagen Bioscience |
275.31 Mn |
208.77 Mn |
19.98 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
22.64% |
| Jun 30, 2025 |
16.86% |
| Mar 31, 2025 |
17.96% |
| Dec 31, 2024 |
11.15% |
| Sep 30, 2024 |
5.55% |
| Jun 30, 2024 |
3.94% |
| Mar 31, 2024 |
5.22% |
| Dec 31, 2023 |
5.41% |
| Sep 30, 2023 |
2.61% |
| Jun 30, 2023 |
0.38% |
| Mar 31, 2023 |
-1.31% |
| Dec 31, 2022 |
-2.93% |
| Sep 30, 2022 |
1.78% |
| Jun 30, 2022 |
7.20% |
| Mar 31, 2022 |
20.25% |
| Dec 31, 2021 |
23.97% |
| Sep 30, 2021 |
26.36% |
| Dec 31, 2020 |
15.39% |
| Mar 31, 2018 |
39.90% |
| Dec 30, 2017 |
47.33% |
